Stay updated with breaking news from Acute Suicidal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Two near-term data catalysts expected in 2023 Entered active collaboration with Alvogen Pharmaceuticals and Lotus Pharmaceuticals for global development and commercialization of NRX-101 in suicidal... -Today at 04:10 pm- MarketScreener
Two near-term data catalysts expected in 2023 Entered active collaboration with Alvogen Pharmaceuticals and Lotus Pharmaceuticals for global development and...
First investigational drug for patients with Severe Bipolar Depression and Acute Suicidal Ideation/Behavior, a high unmet medical need Company received...
Search jobs 19-Feb-2021 Anti-Suicide Drugs Market to Exhibit a Rise by 4.1% CAGR Between 2019 to 2027 | Coherent Market Insights The Global Anti-Suicide Drugs Market, by Drug Class (Anti-Depressant and Anti-Anxiety Drugs, Anti-Psychotic Drugs, NMDA Antagonist, and Antibiotic Analog) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 3,818.1 million in 2018 and is projected to expand at a CAGR of 4.1% during the forecast period (2019–2027). Novel approved drugs, which are expected...